AU2003900505A0 - Anthelmintic composition - Google Patents
Anthelmintic compositionInfo
- Publication number
- AU2003900505A0 AU2003900505A0 AU2003900505A AU2003900505A AU2003900505A0 AU 2003900505 A0 AU2003900505 A0 AU 2003900505A0 AU 2003900505 A AU2003900505 A AU 2003900505A AU 2003900505 A AU2003900505 A AU 2003900505A AU 2003900505 A0 AU2003900505 A0 AU 2003900505A0
- Authority
- AU
- Australia
- Prior art keywords
- anthelmintic composition
- anthelmintic
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 230000000507 anthelmentic effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/275—Nitriles; Isonitriles
- A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
- A61K9/0017—Non-human animal skin, e.g. pour-on, spot-on
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4168—1,3-Diazoles having a nitrogen attached in position 2, e.g. clonidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Tropical Medicine & Parasitology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Dermatology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Priority Applications (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2003900505A AU2003900505A0 (en) | 2003-02-05 | 2003-02-05 | Anthelmintic composition |
| GB0516881A GB2413764B8 (en) | 2003-02-05 | 2004-02-04 | Anthelmintic compostion |
| NZ540391A NZ540391A (en) | 2003-02-05 | 2004-02-04 | Anthelmintic composition |
| AU2004210461A AU2004210461C1 (en) | 2003-02-05 | 2004-02-04 | Anthelmintic composition |
| BRPI0407271A BRPI0407271B1 (en) | 2003-02-05 | 2004-02-04 | anthelmintic composition |
| PCT/AU2004/000126 WO2004069242A1 (en) | 2003-02-05 | 2004-02-04 | Anthelmintic composition |
| ARP040100372A AR043044A1 (en) | 2003-02-05 | 2004-02-05 | ANTIHELMINTIC COMPOSITION |
| AU2009201942A AU2009201942C1 (en) | 2003-02-05 | 2009-05-15 | Anthelmintic composition |
| AU2012200544A AU2012200544C1 (en) | 2003-02-05 | 2012-01-31 | Anthelmintic composition |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2003900505A AU2003900505A0 (en) | 2003-02-05 | 2003-02-05 | Anthelmintic composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2003900505A0 true AU2003900505A0 (en) | 2003-02-20 |
Family
ID=30005205
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2003900505A Abandoned AU2003900505A0 (en) | 2003-02-05 | 2003-02-05 | Anthelmintic composition |
| AU2004210461A Expired AU2004210461C1 (en) | 2003-02-05 | 2004-02-04 | Anthelmintic composition |
| AU2009201942A Expired AU2009201942C1 (en) | 2003-02-05 | 2009-05-15 | Anthelmintic composition |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2004210461A Expired AU2004210461C1 (en) | 2003-02-05 | 2004-02-04 | Anthelmintic composition |
| AU2009201942A Expired AU2009201942C1 (en) | 2003-02-05 | 2009-05-15 | Anthelmintic composition |
Country Status (6)
| Country | Link |
|---|---|
| AR (1) | AR043044A1 (en) |
| AU (3) | AU2003900505A0 (en) |
| BR (1) | BRPI0407271B1 (en) |
| GB (1) | GB2413764B8 (en) |
| NZ (1) | NZ540391A (en) |
| WO (1) | WO2004069242A1 (en) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0316377D0 (en) | 2003-07-12 | 2003-08-13 | Norbrook Lab Ltd | Parasiticidal composition |
| CN101686962B (en) * | 2007-06-29 | 2012-05-23 | 辉瑞大药厂 | Combination of anthelmintics |
| AU2008324095A1 (en) * | 2007-11-09 | 2009-05-14 | Intervet International B.V. | Anthelmintic combination |
| AU2010100349B4 (en) * | 2009-04-15 | 2012-03-29 | Jurox Pty Ltd | Anthelmintic formulation |
| CA3040719C (en) * | 2009-09-07 | 2022-06-14 | Argenta Innovation Limited | Granulated anthelmintic preparations and delivery systems |
| AR081187A1 (en) * | 2010-05-12 | 2012-07-04 | Merial Ltd | INJECTABLE FORMULATIONS PARASITICIDES OF LEVAMISOL AND MACROCICLIC LACTONS. PREPARATION METHOD. TREATMENT METHOD |
| PE20141179A1 (en) | 2011-06-23 | 2014-10-11 | Bayer New Zealand Ltd | AN ANTIPARASITIC COMPOSITION AND METHOD OF TREATMENT |
| NZ594610A (en) | 2011-08-16 | 2013-03-28 | Virbac New Zealand Ltd | Injectable Anthelmintic Formulations cotaining levamisole and one or more macrocyclic lactones for controlling internal parasites in ruminants |
| WO2018038623A1 (en) * | 2016-08-23 | 2018-03-01 | Donaghys Limited | Improvements in parasite treatments |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6340672B1 (en) * | 2000-02-16 | 2002-01-22 | Phoenix Scientific, Inc. | Parasiticidal formulation and a method of making this formulation |
-
2003
- 2003-02-05 AU AU2003900505A patent/AU2003900505A0/en not_active Abandoned
-
2004
- 2004-02-04 BR BRPI0407271A patent/BRPI0407271B1/en active IP Right Grant
- 2004-02-04 WO PCT/AU2004/000126 patent/WO2004069242A1/en not_active Ceased
- 2004-02-04 GB GB0516881A patent/GB2413764B8/en not_active Expired - Lifetime
- 2004-02-04 NZ NZ540391A patent/NZ540391A/en unknown
- 2004-02-04 AU AU2004210461A patent/AU2004210461C1/en not_active Expired
- 2004-02-05 AR ARP040100372A patent/AR043044A1/en unknown
-
2009
- 2009-05-15 AU AU2009201942A patent/AU2009201942C1/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| AU2009201942A1 (en) | 2009-06-04 |
| BRPI0407271A (en) | 2006-01-31 |
| WO2004069242A1 (en) | 2004-08-19 |
| BRPI0407271B1 (en) | 2015-11-10 |
| GB2413764B8 (en) | 2013-10-16 |
| AU2004210461A1 (en) | 2004-08-19 |
| GB0516881D0 (en) | 2005-09-28 |
| AR043044A1 (en) | 2005-07-13 |
| GB2413764B (en) | 2006-12-20 |
| GB2413764A8 (en) | 2013-10-16 |
| AU2004210461B2 (en) | 2009-12-03 |
| AU2009201942B2 (en) | 2012-02-16 |
| GB2413764A (en) | 2005-11-09 |
| AU2004210461C1 (en) | 2017-06-29 |
| NZ540391A (en) | 2006-12-22 |
| AU2009201942C1 (en) | 2017-06-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2003224597A1 (en) | Organic compositions | |
| AU2003285288A1 (en) | Composition | |
| AU2003304507A1 (en) | Anti-coronavirus agent | |
| AU2003300056A1 (en) | Organic compositions | |
| AU2002950744A0 (en) | Composition | |
| AU2003235708A1 (en) | Polytartrate composition | |
| AU2003208411A1 (en) | Anti-glycolytic composition | |
| AU2003269904A1 (en) | Antigen-polymer compositions | |
| AU2003900505A0 (en) | Anthelmintic composition | |
| AU2002338201A1 (en) | Anthelmintic composition | |
| AU2003202905A1 (en) | Organic composition | |
| AU2003902430A0 (en) | Masterbatch composition | |
| AU2003100144A4 (en) | Lousicide composition | |
| AU2003275963A1 (en) | Polymer composition | |
| AU2003208841A1 (en) | Gasolinen compositions | |
| AU2003268772A1 (en) | Oil-barrier composition | |
| AU2003216382A1 (en) | Idothyronine compositions | |
| AU2003218497A1 (en) | FACTORVIIa COMPOSITIONS | |
| AU2003903763A0 (en) | Composition | |
| AU2003280821A1 (en) | Beauveriolide derivative | |
| HK1089377A (en) | Pharmaceutical composition | |
| HK1088245A (en) | Pharmaceutical composition | |
| AU2003902322A0 (en) | Pharmaceutical composition | |
| AU2003266526A1 (en) | Medicinal composition | |
| HK1092702A (en) | Pharmaceutical compositions |